Description
A bioactive sphingolipid; reduces globotriaosylceramide 3 synthesis from exogenous lactosylceramide in microsomes; stimulates recombinant glucocerebrosidase activity in a pH-dependent manner; activates glucocerebrosidase to decrease glucosylceramide accumulation in fibroblasts and lymphoblasts isolated from patients with Gaucher and Fabry disease, respectively,
Formal name: N-[(1S,2R,3E)-1-[(β-D-galactopyranosyloxy)methyl]-2-hydroxy-3-heptadecen-1-yl]-tricyclo[3.3.1.13,7]decane-1-acetamide
Synonyms: AdaGalCer(d18:1/2:0)|Admantanyl Galactosylceramide (d18:1/2:0)|Admantanyl GalCer(d18:1/2:0)|N-(1-adamantaneacetyl) Galactosylceramide
Molecular weight: 637.9
CAS: 574738-16-2
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Lipids|Sphingolipids||Product Type|Biochemicals|Small Molecule Activators||Research Area|Endocrinology & Metabolism|Inborn Errors of Metabolism||Research Area|Lipid Biochemistry|Sphingolipids